Luminex

Kemp Proteins and Columbia Biosciences Announce Strategic Partnership for Fluorophore Conjugation Solutions

Retrieved on: 
Tuesday, April 2, 2024
Partnership, Projection screen, Research, Strategic partnership, Protein, Luminex, Antibody, Drug development, Quality management system, Therapy, Microscopy, Vaccine

FREDERICK, Md., April 2, 2024 /PRNewswire-PRWeb/ -- Kemp Proteins LLC, a leading provider of monoclonal antibody development and gene-to-protein services, announced today that the company has entered a Strategic Partnership with Columbia Biosciences of Frederick, Maryland. With a long history in manufacturing of fluorescent proteins and renowned excellence in protein conjugation, Columbia Biosciences uses its experience to select appropriate fluorophores and conjugation chemistries for target antibodies and proteins. Columbia's technology is broadly applicable in the molecular tools and diagnostic space with applications in Flow Cytometry, Luminex, Western Blot/ELISA, Microscopy and High Throughput Screening. The combination of Kemp's capability to develop and manufacture gram quantities of proteins and monoclonal antibodies for its clients, together with Columbia's superior fluorescent conjugation, will provide a streamlined opportunity to generate client-directed, custom-tailored ready-to-use molecular tools manufactured under ISO13485:2016 compliant Quality Management Systems.

Key Points: 
  • FREDERICK, Md., April 2, 2024 /PRNewswire-PRWeb/ -- Kemp Proteins LLC, a leading provider of monoclonal antibody development and gene-to-protein services, announced today that the company has entered a Strategic Partnership with Columbia Biosciences of Frederick, Maryland.
  • With a long history in manufacturing of fluorescent proteins and renowned excellence in protein conjugation, Columbia Biosciences uses its experience to select appropriate fluorophores and conjugation chemistries for target antibodies and proteins.
  • Under the Partnership, Kemp Proteins will utilize its proven monoclonal antibody development and gene-to-protein capabilities to produce, purify and QC the antibodies/proteins for supply to Columbia Biosciences for fluorescent labeling.
  • This strategic partnership will provide turnkey custom solutions for our biopharma, diagnostic and life science clients," said Michael Keefe, CEO for Kemp Proteins.

MARAbio appoints Gail S. Page as member of Board of Directors

Retrieved on: 
Thursday, March 14, 2024
Labcorp, Incidence, Physician, UC, Vermilion, Child, Pregnancy, Luminex, Water, MIND, University of California, Davis, Spectrum, Parent, Management

SALT LAKE CITY, March 14, 2024 /PRNewswire-PRWeb/ -- MARAbio, whose mission is to detect, treat, and prevent Maternal Autoantibody Related Autism (MARA), has appointed Gail S. Page to its Board of Directors. Ms. Page has more than 30 years of life sciences experience, and currently serves as a partner at pH Blueprint, a strategic advisory firm focused on collaborating with medical device, diagnostics, and biotech clients. She is also a Venture Partner at Turret Capital Management, a global healthcare investment and venture firm. Previously Ms. Page served in executive management roles with LabCorp and Roche Biomedical, as Chief Operating Officer at Luminex, and President & CEO of Vermillion, Inc. Her current and past board appointments include public and private companies.

Key Points: 
  • SALT LAKE CITY, March 14, 2024 /PRNewswire-PRWeb/ -- MARAbio , whose mission is to detect, treat, and prevent Maternal Autoantibody Related Autism (MARA), has appointed Gail S. Page to its Board of Directors.
  • She is also a Venture Partner at Turret Capital Management, a global healthcare investment and venture firm.
  • Page served in executive management roles with LabCorp and Roche Biomedical, as Chief Operating Officer at Luminex, and President & CEO of Vermillion, Inc.
  • "Gail brings significant insights and experience in the diagnostic and clinical lab sectors as a former CEO and other C-level positions, and we are very pleased to welcome her to MARAbio's Board of Directors," said Marnin Kligfeld, Chairman of the Board of MARAbio.

ERS electronic introduces the first semi-automatic machine of its Luminex product line featuring groundbreaking PhotoThermal debonding technology

Retrieved on: 
Wednesday, March 13, 2024
Glass, Therapy, Luminex, New product development, Research, ERS, CLAL

MUNICH, March 13, 2024 /PRNewswire/ -- ERS electronic , the industry leader of thermal management solutions for semiconductor manufacturing is presenting the first machine from its innovative Luminex product line featuring the cutting-edge "PhotoThermal" debonding technology for wafer and panels up to 600 x 600 mm.

Key Points: 
  • MUNICH, March 13, 2024 /PRNewswire/ -- ERS electronic , the industry leader of thermal management solutions for semiconductor manufacturing is presenting the first machine from its innovative Luminex product line featuring the cutting-edge "PhotoThermal" debonding technology for wafer and panels up to 600 x 600 mm.
  • PhotoThermal debonding is a zero stress debonding method that uses a highly controlled flash lamp to separate the carrier from the substrate.
  • ERS 's semi-automatic machine is the first in a series of machines belonging to the Luminex product line.
  • As part of the comprehensive product line, the company will offer the automatic machine with several modular add-ons, further enhancing product quality and yield.

ERS electronic introduces the first semi-automatic machine of its Luminex product line featuring groundbreaking PhotoThermal debonding technology

Retrieved on: 
Wednesday, March 13, 2024
Glass, Therapy, Luminex, New product development, Research, ERS, CLAL

MUNICH, March 13, 2024 /PRNewswire/ -- ERS electronic , the industry leader of thermal management solutions for semiconductor manufacturing is presenting the first machine from its innovative Luminex product line featuring the cutting-edge "PhotoThermal" debonding technology for wafer and panels up to 600 x 600 mm.

Key Points: 
  • MUNICH, March 13, 2024 /PRNewswire/ -- ERS electronic , the industry leader of thermal management solutions for semiconductor manufacturing is presenting the first machine from its innovative Luminex product line featuring the cutting-edge "PhotoThermal" debonding technology for wafer and panels up to 600 x 600 mm.
  • PhotoThermal debonding is a zero stress debonding method that uses a highly controlled flash lamp to separate the carrier from the substrate.
  • ERS 's semi-automatic machine is the first in a series of machines belonging to the Luminex product line.
  • As part of the comprehensive product line, the company will offer the automatic machine with several modular add-ons, further enhancing product quality and yield.

GBK Brand Bar Celebrated their 15th Annual Luxury Lounge prior to Oscars, Presented by Care A2+

Retrieved on: 
Tuesday, March 12, 2024
Storm, Caviar, Safe Haven, Love, Wilshire Grand Center, Safe haven, Beverly Wilshire Hotel, Biomedical Research, Weight loss, Transport, Interview, Invincible, Regenerative medicine, Turks and Caicos Islands, GE Lighting, Hexagon, White, Red, Scott Evans, GBK, Jewellery, Collective identity, CARE, Longevity, Mother, Knight, Menopause, Human, Savant syndrome, Luminex, Red White and Blue, Drink, Good luck, Short, Elemental, Killers, Travel, Doctor of Philosophy, Organic, Electronics, Music, Multimedia, Luxury

BEVERLY HILLS, Calif., March 12, 2024 /PRNewswire/ -- The Biggest Award night in Hollywood, brought out the brightest stars in Entertainment for GBK Brand Bar's 15th Annual Oscar Luxury Lounge at the Beverly Wilshire Hotel, Presented by CARE A2+. GBK Brand Bar presented select guests over $100,000 in various gifts, including 7 different travel getaways, (African Safari, Turks & Caicos, Greece, and many others) Electronics, Jewelry, and 20 other exciting giveaways. As always, there was an amazing selection of beverages & food to nibble on, as well as music from DJ Kara keeping the guests entertained from the moment they entered.

Key Points: 
  • BEVERLY HILLS, Calif., March 12, 2024 /PRNewswire/ -- The Biggest Award night in Hollywood, brought out the brightest stars in Entertainment for GBK Brand Bar's 15th Annual Oscar Luxury Lounge at the Beverly Wilshire Hotel, Presented by CARE A2+.
  • GBK Brand Bar presented select guests over $100,000 in various gifts, including 7 different travel getaways, (African Safari, Turks & Caicos, Greece, and many others) Electronics, Jewelry, and 20 other exciting giveaways.
  • Care A2+ donated product to a local women's shelter in the name of the celebrities present.
  • Any media inquiries and/or interview request, please contact Tad Hamilton of Mosaic Public Relations at: [email protected]
    This press release was issued through 24-7PressRelease.com.

3D Systems Announces Organization Changes and New Executive Leadership Appointments

Retrieved on: 
Wednesday, December 13, 2023
Business transformation, Partnership, Luminex, Economics, Certified Management Accountant, CFO, American Public University System, Luminex Corporation, Marketing, Pfeiffer University, Regenerative medicine, Harriss, MBA, Certified Public Accountant, Interim management, University, Moses Austin, Interim, Growth, ROCK, 3D Systems, Senior, Management

ROCK HILL, S.C., Dec. 13, 2023 (GLOBE NEWSWIRE) -- Today, 3D Systems (NYSE:DDD) announced two additions to its executive leadership team.

Key Points: 
  • ROCK HILL, S.C., Dec. 13, 2023 (GLOBE NEWSWIRE) -- Today, 3D Systems (NYSE:DDD) announced two additions to its executive leadership team.
  • Mr. Creech joins 3D Systems with more than 25 years of experience in financial leadership and business transformation.
  • Mr. Currie will be joining 3D Systems with 30 years of experience in executive leadership with a focus on building emerging businesses.
  • “I’m pleased to welcome Jeffrey and Harriss to 3D Systems in these very important roles,” said Dr. Jeffrey Graves, president & CEO, 3D Systems.

Luminex Resources Announces Revised Pegasus Earn-In Terms with Anglo-American

Retrieved on: 
Wednesday, December 20, 2023
Pegasus, Anglo American, Luminex, Anglo American plc, Amend

VANCOUVER, BC, Dec. 20, 2023 /PRNewswire/ - Luminex Resources Corp. (TSXV: LR) (OTCQX: LUMIF) (the "Company" or "Luminex") is pleased to advise that it has successfully reached agreement with a subsidiary of Anglo American plc ("Anglo American") to amend and restate the Pegasus earn-in and joint venture agreement ("Amended Earn-In Agreement").

Key Points: 
  • VANCOUVER, BC, Dec. 20, 2023 /PRNewswire/ - Luminex Resources Corp. (TSXV: LR) (OTCQX: LUMIF) (the "Company" or "Luminex") is pleased to advise that it has successfully reached agreement with a subsidiary of Anglo American plc ("Anglo American") to amend and restate the Pegasus earn-in and joint venture agreement ("Amended Earn-In Agreement").
  • Luminex will also be owed US$3.9M by way of cash payments to complete the earn-in to 60% ownership.
  • Full details regarding the revised earn-in terms and schedule are below in Table 1.
  • Anglo American will also apply to reduce the concession size at Pegasus A based on field work completed since 2018.

Luminex Resources Announces Annual Shareholder Meeting Results

Retrieved on: 
Wednesday, November 15, 2023
Meeting, Remuneration, Luminex

VANCOUVER, BC, Nov. 15, 2023 /PRNewswire/ - Lumina Gold Corp. (TSXV: LR) (OTCQX: LUMIF) (the "Company" or "Luminex") is pleased to announce the results of its annual general and special meeting of shareholders held on November 15, 2023 in Vancouver (the "Meeting").

Key Points: 
  • VANCOUVER, BC, Nov. 15, 2023 /PRNewswire/ - Lumina Gold Corp. (TSXV: LR) (OTCQX: LUMIF) (the "Company" or "Luminex") is pleased to announce the results of its annual general and special meeting of shareholders held on November 15, 2023 in Vancouver (the "Meeting").
  • Luminex's shareholders voted in favour of each of the matters considered at the Meeting, including:
    Electing each of Marshall Koval, Lyle Braaten, Donald Shumka, David Farrell and John Wright as directors of the Company to hold office for the ensuing year;
    Appointing auditors for the ensuing year and authorizing the board of directors to set their remuneration; and
    Approving Luminex's new omnibus equity compensation plan.

Cytek Biosciences Reports Third Quarter 2023 Financial Results

Retrieved on: 
Tuesday, November 7, 2023
Research, Security (finance), Luminex Corporation, EBITDA, Acquisition, Organic, Environment, Growth, Marketing, Total, Investment, Video game, Cryptocurrency, Luminex

FREMONT, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial results for the third quarter ended September 30, 2023.

Key Points: 
  • FREMONT, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial results for the third quarter ended September 30, 2023.
  • Gross profit margin was 57% in the third quarter of 2023 compared to 66% in the third quarter of 2022.
  • Research and development expenses were $11.2 million for the third quarter of 2023 compared to $8.7 million for the third quarter of 2022.
  • Cytek will host a conference call to discuss the third quarter 2023 financial results on Tuesday, November 7, 2023, at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Discovery Life Sciences Announces Major Strategic Expansions: New State-of-the-Art Facilities, Advanced Technologies, and Global Brand Enhancements

Retrieved on: 
Thursday, October 12, 2023
Acquisition, Target, Research, HT, Mass spectrometry, Health, Flow cytometry, Luminex, Collection, Biological specimen, Growth, Protein, Cell biology, Fine chemical, Online shopping, Discovery, EU

HUNTSVILLE, Ala., Oct. 12, 2023 /PRNewswire/ -- Discovery Life Sciences (Discovery), the Biospecimen and Biomarker Specialists, has moved to its new global headquarters at the HudsonAlpha Institute of Biotechnology campus in Huntsville, Alabama.

Key Points: 
  • HUNTSVILLE, Ala., Oct. 12, 2023 /PRNewswire/ -- Discovery Life Sciences (Discovery), the Biospecimen and Biomarker Specialists, has moved to its new global headquarters at the HudsonAlpha Institute of Biotechnology campus in Huntsville, Alabama.
  • Alongside this relocation, the company's AllCells cell and gene therapy division has set up its new divisional headquarters in Alameda, California.
  • In addition, Discovery is introducing Olink Explore HT proteomic services and debuting an all-new digital platform.
  • With support from the State of Alabama and HudsonAlpha, Discovery has opened its new 93,000-square-foot global headquarters building in Huntsville.